• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYP2B6 相关的药物遗传学标记物与 HIV-1 感染泰国成年人中依非韦伦的血浆浓度相关。

Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults.

机构信息

Laboratory for Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Br J Clin Pharmacol. 2012 Dec;74(6):1005-12. doi: 10.1111/j.1365-2125.2012.04288.x.

DOI:10.1111/j.1365-2125.2012.04288.x
PMID:22471906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3522814/
Abstract

AIMS

To investigate the frequency of CYP2B6 polymorphisms and the influence of haplotype structure on plasma efavirenz concentrations in Thai adults with HIV-1 infection.

METHODS

Genotyping of nine single nucleotide polymorphisms (SNPs, c.64C>T, c.499C>G, c.516G>T, c.785A>G, c.1375A>G, c.1459C>T, g.3003T>C, g.18492C>T and g.21563C>T) of CYP2B6 were performed using real-time PCR-based allelic discrimination on blood samples from 52 HIV-infected adults who had received an efavirenz-based regimen. Plasma efavirenz concentrations were measured by high performance liquid chromatography.

RESULTS

The minor allele frequencies for c.64C>T, c.516G>T, c.785A>G, g.3003C>T, g.18492T>C and g.21563C>T were 0.087, 0.365, 0.413, 0.308 and 0.356, respectively. However, no variant alleles were identified for three SNPs (c.499 C>G, c.1375 A>G and c.1459 C>T). Efavirenz plasma concentrations were significantly associated with c.516G>T (P= 0.0095), c.785A>G (P= 0.0017), g.21563C>T (P= 0.0036) and g.18492C>T (P= 0.0011). The composite CYP2B6 of three SNPs (c.516G ≥ T, c.785A ≥ G and g.21563C ≥ T) genotypes were significantly associated with higher efavirenz concentrations.

CONCLUSIONS

Our data indicate that the GAC-CYP2B6 haplotype is associated with higher plasma efavirenz concentrations in HIV-infected Thai adults.

摘要

目的

研究 CYP2B6 多态性的频率及其单倍型结构对泰国 HIV-1 感染成人患者体内依非韦伦血药浓度的影响。

方法

采用实时 PCR 等位基因鉴别法对 52 例接受依非韦伦为基础方案治疗的 HIV 感染成人患者的血液样本进行 CYP2B6 9 个单核苷酸多态性(SNP,c.64C>T、c.499C>G、c.516G>T、c.785A>G、c.1375A>G、c.1459C>T、g.3003T>C、g.18492C>T 和 g.21563C>T)的基因分型。采用高效液相色谱法测定依非韦伦的血药浓度。

结果

c.64C>T、c.516G>T、c.785A>G、g.3003C>T、g.18492T>C 和 g.21563C>T 的次要等位基因频率分别为 0.087、0.365、0.413、0.308 和 0.356。然而,三个 SNP(c.499C>G、c.1375A>G 和 c.1459C>T)未发现变异等位基因。依非韦伦血药浓度与 c.516G>T(P=0.0095)、c.785A>G(P=0.0017)、g.21563C>T(P=0.0036)和 g.18492C>T(P=0.0011)显著相关。三个 SNP(c.516G>T、c.785A>G 和 g.21563C>T)的复合 CYP2B6 基因型与较高的依非韦伦浓度显著相关。

结论

我们的数据表明,GAC-CYP2B6 单倍型与泰国 HIV 感染成人患者体内较高的依非韦伦血药浓度有关。

相似文献

1
Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults.CYP2B6 相关的药物遗传学标记物与 HIV-1 感染泰国成年人中依非韦伦的血浆浓度相关。
Br J Clin Pharmacol. 2012 Dec;74(6):1005-12. doi: 10.1111/j.1365-2125.2012.04288.x.
2
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.CYP2B6 基因多态性标志物、临床因素和药物相互作用对 HIV/结核分枝杆菌共感染患者中依非韦伦浓度的影响。
Antimicrob Agents Chemother. 2013 Feb;57(2):1019-24. doi: 10.1128/AAC.02023-12. Epub 2012 Dec 17.
3
CYP2B6 18492T->C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype *1/*1.细胞色素P450 2B6(CYP2B6)基因18492位点的T→C多态性会降低携带CYP2B6单倍型*1/*1的HIV合并结核感染患者体内依非韦伦的血药浓度。
Antimicrob Agents Chemother. 2014;58(4):2268-73. doi: 10.1128/AAC.02384-13. Epub 2014 Feb 3.
4
High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections.高血浆依非韦伦浓度和泰国 HIV-1 感染中 CYP2B6 多态性。
Drug Metab Pharmacokinet. 2013;28(5):391-7. doi: 10.2133/dmpk.dmpk-12-rg-120. Epub 2013 Feb 12.
5
Effects of cytochrome P450 2B6 and constitutive androstane receptor genetic variation on Efavirenz plasma concentrations among HIV patients in Kenya.肯尼亚 HIV 患者细胞色素 P450 2B6 和组成型雄烷受体遗传变异对依非韦伦血药浓度的影响。
PLoS One. 2022 Mar 2;17(3):e0260872. doi: 10.1371/journal.pone.0260872. eCollection 2022.
6
CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy.CYP2B6 单倍型及生物因素导致接受依非韦伦为基础的抗反转录病毒治疗的 HIV 感染患者发生肝毒性。
Int J Antimicrob Agents. 2014 Mar;43(3):292-6. doi: 10.1016/j.ijantimicag.2013.10.022. Epub 2013 Nov 25.
7
CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.细胞色素P450 2B6(c.516G→T)和细胞色素P450 2A6(*9B和/或*17)基因多态性是HIV感染患者中依非韦伦血浆浓度的独立预测指标。
Br J Clin Pharmacol. 2009 Apr;67(4):427-36. doi: 10.1111/j.1365-2125.2009.03368.x.
8
High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients.南非 HIV/AIDS 患者中 CYP2B6 单核苷酸多态性对稳态血浆依非韦伦水平的高预测价值。
Pharmacogenet Genomics. 2013 Aug;23(8):415-27. doi: 10.1097/FPC.0b013e328363176f.
9
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.CYP2B6基因983T>C多态性对HIV感染患者非核苷类逆转录酶抑制剂血浆浓度的影响。
J Antimicrob Chemother. 2008 Apr;61(4):914-8. doi: 10.1093/jac/dkn029. Epub 2008 Feb 14.
10
Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.CYP2B6 多态性对预防 HIV 感染泰国妇女母婴传播单次围产期应用奈韦拉平后血浆奈韦拉平浓度持续的影响。
J Antimicrob Chemother. 2009 Dec;64(6):1265-73. doi: 10.1093/jac/dkp351. Epub 2009 Oct 6.

引用本文的文献

1
Pharmacogenomic profiling of variants affecting efficacy and toxicity of anti-infective medicines in a south Asian population from Sri Lanka.斯里兰卡南亚人群中影响抗感染药物疗效和毒性的变异体的药物基因组学分析。
BMC Infect Dis. 2025 Feb 1;25(1):153. doi: 10.1186/s12879-025-10538-w.
2
Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer's Disease Therapeutics.考虑将依非韦伦用于阿尔茨海默病治疗的药物重新利用的挑战与机遇
ACS Pharmacol Transl Sci. 2024 Sep 6;7(10):2924-2935. doi: 10.1021/acsptsci.4c00229. eCollection 2024 Oct 11.
3
Sub- and supratherapeutic efavirenz plasma concentrations with risk for HIV therapy failure are mainly genetically explained in Ugandan children: The prospective GENEFA cohort study.乌干达儿童中依非韦伦血浆浓度低于和高于治疗水平且存在HIV治疗失败风险主要由基因因素导致:前瞻性GENEFA队列研究
Br J Clin Pharmacol. 2025 Feb;91(2):464-478. doi: 10.1111/bcp.16272. Epub 2024 Oct 8.
4
Synthesis of mono Cytochrome P450 in a modified CHO-CPR cell-free protein production platform.在改良的 CHO-CPR 无细胞蛋白生产平台中合成单细胞色素 P450。
Sci Rep. 2024 Jan 13;14(1):1271. doi: 10.1038/s41598-024-51781-6.
5
The Effects of Cumulative Dose and Polymorphisms in CYP2B6 on the Mitotane Plasma Trough Concentrations in Chinese Patients With Advanced Adrenocortical Carcinoma.CYP2B6基因累积剂量和多态性对中国晚期肾上腺皮质癌患者米托坦血浆谷浓度的影响
Front Oncol. 2022 Jun 30;12:919027. doi: 10.3389/fonc.2022.919027. eCollection 2022.
6
The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population.巴基斯坦人群中药基因组学变异的患病率及其临床相关性。
Evol Bioinform Online. 2022 Apr 24;18:11769343221095834. doi: 10.1177/11769343221095834. eCollection 2022.
7
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.用于改善新冠病毒疾病治疗的药物遗传学和精准医学方法。
Front Pharmacol. 2022 Feb 18;13:835136. doi: 10.3389/fphar.2022.835136. eCollection 2022.
8
Effects of cytochrome P450 2B6 and constitutive androstane receptor genetic variation on Efavirenz plasma concentrations among HIV patients in Kenya.肯尼亚 HIV 患者细胞色素 P450 2B6 和组成型雄烷受体遗传变异对依非韦伦血药浓度的影响。
PLoS One. 2022 Mar 2;17(3):e0260872. doi: 10.1371/journal.pone.0260872. eCollection 2022.
9
Influence of Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients.多态性对泰国HIV-1患者血浆依法韦仑浓度的影响。
Pharmgenomics Pers Med. 2021 Jul 24;14:915-926. doi: 10.2147/PGPM.S306358. eCollection 2021.
10
Role of Genetic Variations in the Hepatic Handling of Drugs.遗传变异在药物肝脏处理中的作用。
Int J Mol Sci. 2020 Apr 20;21(8):2884. doi: 10.3390/ijms21082884.

本文引用的文献

1
Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms.依非韦伦血药浓度与细胞色素 2B6 多态性。
Ann Pharmacother. 2010 Oct;44(10):1572-8. doi: 10.1345/aph.1P141. Epub 2010 Sep 14.
2
Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort.CYP2B6 单倍型结构与智利 HIV 队列中依非韦伦血药浓度的关联。
J Antimicrob Chemother. 2010 Sep;65(9):1889-93. doi: 10.1093/jac/dkq260. Epub 2010 Jul 17.
3
CYP2B6 polymorphism and nonnucleoside reverse transcriptase inhibitor plasma concentrations in Chinese HIV-infected patients.中国 HIV 感染患者 CYP2B6 多态性与非核苷类逆转录酶抑制剂血药浓度。
Ther Drug Monit. 2010 Oct;32(5):573-8. doi: 10.1097/FTD.0b013e3181ea953c.
4
Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.CYP2B6 多态性对预防 HIV 感染泰国妇女母婴传播单次围产期应用奈韦拉平后血浆奈韦拉平浓度持续的影响。
J Antimicrob Chemother. 2009 Dec;64(6):1265-73. doi: 10.1093/jac/dkp351. Epub 2009 Oct 6.
5
CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients.CYP2B6、CYP2A6 和 UGT2B7 基因多态性是 HIV 感染患者中依非韦伦中剂量浓度的预测因子。
AIDS. 2009 Oct 23;23(16):2101-6. doi: 10.1097/QAD.0b013e3283319908.
6
Plasma efavirenz concentrations and the association with CYP2B6-516G >T polymorphism in HIV-infected Thai children.泰国感染HIV儿童的血浆依非韦伦浓度及其与CYP2B6-516G>T基因多态性的关联
Antivir Ther. 2009;14(3):315-20.
7
Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients.细胞色素P450 2B6基因型对人类免疫缺陷病毒患者中依非韦伦群体药代动力学的影响。
Antimicrob Agents Chemother. 2009 Jul;53(7):2791-8. doi: 10.1128/AAC.01537-08. Epub 2009 May 11.
8
CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.细胞色素P450 2B6(c.516G→T)和细胞色素P450 2A6(*9B和/或*17)基因多态性是HIV感染患者中依非韦伦血浆浓度的独立预测指标。
Br J Clin Pharmacol. 2009 Apr;67(4):427-36. doi: 10.1111/j.1365-2125.2009.03368.x.
9
CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.细胞色素P450 2B6:对一种长期被忽视的细胞色素P450同工酶的新见解
Curr Drug Metab. 2008 Sep;9(7):598-610. doi: 10.2174/138920008785821710.
10
High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe.CYP2B6 516G→T(*6)变体在津巴布韦艾滋病毒/艾滋病门诊患者中的高流行率及其对依非韦伦群体药代动力学的影响。
Eur J Clin Pharmacol. 2008 Apr;64(4):357-65. doi: 10.1007/s00228-007-0412-3. Epub 2007 Dec 5.